BLU
Income statement / Annual
Last year (2022), BELLUS Health Inc.'s total revenue was $16.00 K,
a decrease of 0.00% from the previous year.
In 2022, BELLUS Health Inc.'s net income was -$76.08 M.
See BELLUS Health Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
| Period Ended |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
12/31/2013 |
| Operating Revenue |
$16.00 K |
$16.00 K |
$15.00 K |
$26.79 K |
$25.70 K |
$131.21 K |
$1.41 M |
$2.90 M |
$2.05 M |
$2.12 M |
| Cost of Revenue |
$3.51 B
|
$2.22 B
|
$1.43 B
|
$994.51 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$137.23 K
|
| Gross Profit |
-$3.51 B
|
-$2.22 B
|
-$1.43 B
|
-$994.49 M
|
$25.70 K
|
$131.21 K
|
$1.41 M
|
$2.90 M
|
$2.05 M
|
$2.26 M
|
| Gross Profit Ratio |
-219671.04
|
-138871.74
|
-95361.2
|
-37117.41
|
1
|
1
|
1
|
1
|
1
|
1.06
|
| Research and Development Expenses |
$58.89 M
|
$59.79 M
|
$23.73 M
|
$20.00 M
|
$5.28 M
|
$2.87 M
|
$1.13 M
|
$931.76 K
|
$1.46 M
|
$1.19 M
|
| General & Administrative Expenses |
$19.50 M
|
$14.26 M
|
$9.74 M
|
$6.68 M
|
$2.50 M
|
$2.01 M
|
$1.95 M
|
$2.25 M
|
$2.71 M
|
$4.01 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$19.50 M
|
$14.26 M
|
$9.74 M
|
$6.68 M
|
$2.50 M
|
$2.01 M
|
$1.95 M
|
$2.25 M
|
$2.71 M
|
$4.01 M
|
| Other Expenses |
-$491.00 K
|
-$754.00 K
|
-$507.00 K
|
-$543.53 K
|
-$479.43 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$77.90 M
|
$73.30 M
|
$32.96 M
|
$26.13 M
|
$7.30 M
|
$4.65 M
|
$2.97 M
|
$2.98 M
|
$4.17 M
|
$5.21 M
|
| Cost And Expenses |
$77.90 M
|
$73.30 M
|
$32.96 M
|
$26.13 M
|
$7.30 M
|
$4.65 M
|
$2.97 M
|
$2.98 M
|
$4.17 M
|
$5.21 M
|
| Interest Income |
$5.08 M
|
$233.00 K
|
$1.05 M
|
$1.16 M
|
$265.78 K
|
$63.62 K
|
$74.40 K
|
$104.49 K
|
$170.56 K
|
$189.71 K
|
| Interest Expense |
$78.00 K
|
$55.00 K
|
$39.00 K
|
$22.97 K
|
$3.67 K
|
$8.75 K
|
$8.18 K
|
$7.93 K
|
$89.59 K
|
$133.36 K
|
| Depreciation & Amortization |
$5.12 M
|
$426.00 K
|
$1.22 M
|
$1.28 M
|
$325.25 K
|
$63.62 K
|
$49.10 K
|
$104.49 K
|
$345.43 K
|
$658.36 K
|
| EBITDA |
-$72.76 M |
-$72.86 M |
-$30.49 M |
-$24.82 M |
-$6.95 M |
-$4.46 M |
-$1.51 M |
$28.10 K |
-$1.78 M |
-$2.43 M |
| EBITDA Ratio |
-4547.69
|
-4553.63
|
-2032.93
|
-926.37
|
-270.38
|
-33.97
|
-1.07
|
0.01
|
-0.87
|
-1.15
|
| Operating Income Ratio |
-4867.69
|
-4580.25
|
-2196.13
|
-974.32
|
-283.04
|
-34.45
|
-1.11
|
-0.03
|
-1.04
|
-1.46
|
| Total Other Income/Expenses Net |
$1.86 M
|
$1.86 M
|
$1.19 M
|
-$280.19 K
|
$603.51 K
|
$3.08 M
|
-$86.30 K
|
$348.78 K
|
$389.37 K
|
$2.18 M
|
| Income Before Tax |
-$76.02 M
|
-$71.42 M
|
-$31.76 M
|
-$26.39 M
|
-$6.67 M
|
-$1.44 M
|
-$1.65 M
|
$272.40 K
|
-$1.74 M
|
-$911.93 K
|
| Income Before Tax Ratio |
-4751.25
|
-4463.94
|
-2117.13
|
-984.77
|
-259.55
|
-10.99
|
-1.17
|
0.09
|
-0.85
|
-0.43
|
| Income Tax Expense |
$60.00 K
|
-$199.00 K
|
$39.00 K
|
$22.97 K
|
-$607.18 K
|
$48.51 K
|
$11.16 K
|
-$19.46 K
|
-$42.21 K
|
-$617.97 K
|
| Net Income |
-$76.08 M
|
-$71.22 M
|
-$31.80 M
|
-$26.41 M
|
-$6.06 M
|
-$1.49 M
|
-$1.61 M
|
$145.57 K
|
-$1.66 M
|
-$818.96 K
|
| Net Income Ratio |
-4755
|
-4451.5
|
-2119.73
|
-985.63
|
-235.92
|
-11.36
|
-1.14
|
0.05
|
-0.81
|
-0.39
|
| EPS |
-0.66 |
-0.9 |
-0.54 |
-0.49 |
-0.18 |
-0.0781 |
-0.099 |
0.011 |
-0.13 |
-0.0622 |
| EPS Diluted |
-0.66 |
-0.9 |
-0.54 |
-0.49 |
-0.18 |
-0.0781 |
-0.099 |
0.011 |
-0.13 |
-0.0622 |
| Weighted Average Shares Out |
$115.36 M
|
$79.32 M
|
$59.02 M
|
$53.41 M
|
$33.62 M
|
$19.07 M
|
$16.22 M
|
$13.17 M
|
$13.17 M
|
$13.17 M
|
| Weighted Average Shares Out Diluted |
$115.36 M
|
$79.32 M
|
$59.02 M
|
$53.41 M
|
$33.62 M
|
$19.07 M
|
$16.22 M
|
$13.17 M
|
$13.17 M
|
$13.17 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
